Search
Becton Dickinson and Co
BDXAdd to Watchlist
144.800USD
+4.090+2.91%
Market hours （ET）Quotes delayed by 15 min
39.90BMarket Cap
36.48P/E TTM
More Details of Becton Dickinson and Co Company
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Becton Dickinson and Co Info
Ticker SymbolBDX
Company nameBecton Dickinson and Co
IPO dateOct 31, 2099
CEOPolen (Thomas E)
Number of employees72000
Security typeOrdinary Share
Fiscal year-endOct 31
AddressOne Becton Drive
CityFRANKLIN LAKES
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07417-1880
Phone12018476800
Websitehttps://www.bd.com/
Ticker SymbolBDX
IPO dateOct 31, 2099
CEOPolen (Thomas E)
Company Executives of Becton Dickinson and Co
Name
Name/Position
Position
Shareholding
Change
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-816.87%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
61.16K
+1.80%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
53.67K
-2.14%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+17.46%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+0.78%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+22.14%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
10.38K
+10.57%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
7.15K
+15.35%
Mr. Vitor Roque
Mr. Vitor Roque
Interim Chief Financial Officer
Interim Chief Financial Officer
7.13K
+24.14%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+28.47%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-816.87%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
61.16K
+1.80%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
53.67K
-2.14%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+17.46%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+0.78%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+22.14%
FAQs
Who are the top five shareholders of Becton Dickinson and Co?
The top five shareholders of Becton Dickinson and Co are: Mr. Richard (Rick) Byrd
How many institutions hold shares of Becton Dickinson and Co (BDX)?
As of 2026Q1, 2890 institutions hold shares of Becton Dickinson and Co, with a combined market value of approximately 241.06M, accounting for 87.47% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -46775483.00.
What is the biggest source of revenue for Becton Dickinson and Co?
In 2026Q1, the Medication Delivery Solutions business generated the highest revenue for Becton Dickinson and Co, amounting to 430.00M and accounting for 20.58% of total revenue.
